NeuroLux, Inc.
PrivateLast Round
Grant
Sep 1, 2024
Total Funding Raised
$6.97M
Company Overview
NeuroLux, Inc. is a biotechnology company that develops and manufactures wireless, battery-free, and fully implantable optogenetic and physiological monitoring devices for neuroscience research.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Biotechnology, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroLux, Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
NeuroLux, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 1, 2024 | ||||
| Grant | Aug 15, 2024 | ||||
| Grant | Sep 22, 2022 | ||||
| Grant | Apr 1, 2022 | ||||
| Grant | Jun 1, 2021 | ||||
Grant | Sep 1, 2019 |
Key People
Founding team and executive leadership
NeuroLux, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Drug Abuse | Grant |
| National Institute on Aging | Grant |
| National Institutes of Health (NIH) | Grant |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development | Grant |
| National Institute of Mental Health | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2017
$1.5M grant from the National Institute of Mental Health.
NeuroLux, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeuroLux, Inc.'s valuation, stock price, and market status.